HK1083341A1 - Stable crystal of 4-oxoquinoline compound - Google Patents
Stable crystal of 4-oxoquinoline compoundInfo
- Publication number
- HK1083341A1 HK1083341A1 HK06105469.5A HK06105469A HK1083341A1 HK 1083341 A1 HK1083341 A1 HK 1083341A1 HK 06105469 A HK06105469 A HK 06105469A HK 1083341 A1 HK1083341 A1 HK 1083341A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- stable crystal
- oxoquinoline compound
- oxoquinoline
- compound
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004150979 | 2004-05-20 | ||
PCT/JP2005/009604 WO2005113508A1 (en) | 2004-05-20 | 2005-05-19 | Stable crystal of 4-oxoquinoline compound |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1083341A1 true HK1083341A1 (en) | 2006-06-30 |
Family
ID=35079161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06105469.5A HK1083341A1 (en) | 2004-05-20 | 2006-05-11 | Stable crystal of 4-oxoquinoline compound |
Country Status (32)
Country | Link |
---|---|
US (6) | US7635704B2 (sl) |
EP (4) | EP4299563A3 (sl) |
JP (1) | JP3754064B2 (sl) |
KR (1) | KR20080064909A (sl) |
CN (1) | CN1956961B (sl) |
AR (2) | AR049280A1 (sl) |
AU (1) | AU2005245296B2 (sl) |
BR (1) | BRPI0510114B8 (sl) |
CA (1) | CA2566922C (sl) |
CY (1) | CY1113010T1 (sl) |
DK (2) | DK3281939T3 (sl) |
ES (2) | ES2960824T3 (sl) |
FI (2) | FI3281939T3 (sl) |
FR (1) | FR23C1040I1 (sl) |
HK (1) | HK1083341A1 (sl) |
HR (2) | HRP20231588T3 (sl) |
HU (2) | HUE064615T2 (sl) |
IL (1) | IL179250A0 (sl) |
LT (1) | LT3281939T (sl) |
MX (1) | MXPA06013405A (sl) |
MY (1) | MY134672A (sl) |
NO (6) | NO339223B1 (sl) |
NZ (1) | NZ551839A (sl) |
PE (2) | PE20120361A1 (sl) |
PL (2) | PL3281939T3 (sl) |
PT (2) | PT1636190E (sl) |
RS (2) | RS52375B (sl) |
RU (1) | RU2330845C1 (sl) |
SI (2) | SI1636190T1 (sl) |
TW (1) | TWI329015B (sl) |
WO (1) | WO2005113508A1 (sl) |
ZA (1) | ZA200610647B (sl) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6891227B2 (en) | 2002-03-20 | 2005-05-10 | International Business Machines Corporation | Self-aligned nanotube field effect transistor and method of fabricating same |
SK2662004A3 (sk) * | 2002-11-20 | 2005-06-02 | Japan Tobacco, Inc. | Zlúčenina s obsahom 4-oxochinolínu a jej použitie ako inhibítora integráz |
MY134672A (en) * | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
WO2007063869A1 (ja) * | 2005-11-30 | 2007-06-07 | Japan Tobacco Inc. | 高純度キノロン化合物の製造方法 |
AU2013203476C1 (en) * | 2005-12-30 | 2016-11-17 | Gilead Sciences, Inc. | Methods for improving the pharmacokinetics of hiv integrase inhibitors |
EA201201496A1 (ru) * | 2005-12-30 | 2013-07-30 | Джилид Сайэнс, Инк. | Способ ингибирования интегразы вич, способ улучшения фармакокинетики 6-(3-хлор-2-фторбензил)-1-[(2s)-1-гидрокси-3-метилбутан-2-ил]-7-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновой кислоты (варианты), набор, фармацевтическая композиция (варианты) и антиретровирусный агент (варианты) |
US20090233964A1 (en) * | 2005-12-30 | 2009-09-17 | Gilead Sciences, Inc. | Methods for improving the pharmacokinetics of hiv integrase inhibitors |
JP2009525261A (ja) * | 2006-02-01 | 2009-07-09 | 日本たばこ産業株式会社 | レトロウイルス感染症の治療のための、6−(3−クロロ−2−フルオロベンジル)−1−[(2s)−1−ヒドロキシ−3−メチルブタン−2−イル]−7−メトキシ−4−オキソ−1,4−ジヒドロキノリン−3−カルボン酸またはその塩の使用 |
WO2007092802A1 (en) * | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Method for treating hiv infection through co-administration of tipranavir and gs 9137 |
AP2914A (en) * | 2006-03-06 | 2014-05-31 | Japan Tobacco Inc | Method for producing 4-oxoquinoline compound |
WO2007102499A1 (ja) | 2006-03-06 | 2007-09-13 | Japan Tobacco Inc. | 4-オキソキノリン化合物の製造方法 |
EA020489B1 (ru) | 2006-07-07 | 2014-11-28 | Джилид Сайэнс, Инк. | Модуляторы фармакокинетических свойств лекарственных средств |
WO2008033836A2 (en) | 2006-09-12 | 2008-03-20 | Gilead Sciences, Inc. | Process and intermediates for preparing integrase inhibitors |
SG183059A1 (en) * | 2007-02-23 | 2012-08-30 | Gilead Sciences Inc | Modulators of pharmacokinetic properties of therapeutics |
NZ582089A (en) * | 2007-06-29 | 2013-01-25 | Gilead Sciences Inc | Antiviral Combination of elvitegravir, lopinavir and optionally ritonavir |
AR067183A1 (es) * | 2007-06-29 | 2009-09-30 | Gilead Sciences Inc | Composiciones terapeuticas y metodos, usos y equipos |
AR068403A1 (es) * | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
PL2296633T3 (pl) | 2008-05-02 | 2016-03-31 | Gilead Sciences Inc | Zastosowanie cząsteczek stałych nośników dla udoskonalenia przetwarzalności środka farmaceutycznego |
MX2011008289A (es) | 2009-02-06 | 2011-09-15 | Gilead Sciences Inc | Tabletas para terapia combinada. |
WO2010137032A2 (en) * | 2009-05-14 | 2010-12-02 | Matrix Laboratories Ltd. | Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts |
WO2011004389A2 (en) * | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | An improved process for the preparation of elvitegravir |
CN102212032B (zh) * | 2011-04-20 | 2013-07-31 | 复旦大学 | 一种5-羟基喹诺酮类衍生物及其制备方法和用途 |
EP2870138B1 (en) | 2012-07-06 | 2018-08-22 | Genentech, Inc. | N-substituted benzamides and methods of use thereof |
EP2880017B1 (en) | 2012-08-03 | 2016-10-05 | Gilead Sciences, Inc. | Process and intermediates for preparing integrase inhibitors |
CN103819402B (zh) * | 2012-11-17 | 2016-03-30 | 上海迪赛诺化学制药有限公司 | 埃替拉韦中间体及其制备方法和应用 |
CN103864682B (zh) * | 2012-12-18 | 2016-12-28 | 上海迪赛诺化学制药有限公司 | 一种制备iii型埃替拉韦晶体的方法 |
DK3067358T3 (da) | 2012-12-21 | 2019-11-04 | Gilead Sciences Inc | Polycykliske carbamoylpyridon-forbindelser og deres farmaceutiske anvendelse |
PT3019503T (pt) | 2013-07-12 | 2017-11-27 | Gilead Sciences Inc | Compostos carbamoílpiridona- policíclicos e seu uso para o tratamento de infecções por hiv |
NO2865735T3 (sl) | 2013-07-12 | 2018-07-21 | ||
CN105315203A (zh) * | 2014-06-06 | 2016-02-10 | 上海迪赛诺化学制药有限公司 | 一种v型埃替拉韦晶体及其制备方法 |
TWI744723B (zh) | 2014-06-20 | 2021-11-01 | 美商基利科學股份有限公司 | 多環型胺甲醯基吡啶酮化合物之合成 |
NO2717902T3 (sl) | 2014-06-20 | 2018-06-23 | ||
TW201613936A (en) | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
TWI738321B (zh) | 2014-12-23 | 2021-09-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
KR20190057158A (ko) | 2015-04-02 | 2019-05-27 | 길리애드 사이언시즈, 인코포레이티드 | 폴리시클릭-카르바모일피리돈 화합물 및 그의 제약 용도 |
CN106008195B (zh) * | 2016-05-19 | 2018-08-03 | 绍兴文理学院 | 一种2,4-二氟-5-碘苯甲酸的制备方法 |
EP3984536A1 (en) * | 2020-10-19 | 2022-04-20 | Centre national de la recherche scientifique | Inhibition of the hiv-1 replication by compounds directed against a new target of the viral cycle |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472859A (en) * | 1966-11-01 | 1969-10-14 | Sterling Drug Inc | 1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters |
JPS567162B1 (sl) | 1970-09-14 | 1981-02-16 | ||
JPS4826772A (sl) | 1971-08-11 | 1973-04-09 | ||
JPS6450979A (en) | 1987-08-21 | 1989-02-27 | Hitachi Shipbuilding Eng Co | Method for discriminating whistle sound |
JPH0651229B2 (ja) | 1989-07-31 | 1994-07-06 | 新日本製鐵株式会社 | プラズマアーク溶接方法および装置 |
IL100555A (en) | 1991-02-07 | 2000-08-31 | Hoechst Marion Roussel Inc | N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them |
JP2993316B2 (ja) | 1992-05-27 | 1999-12-20 | 宇部興産株式会社 | アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤 |
NO304832B1 (no) | 1992-05-27 | 1999-02-22 | Ube Industries | Aminokinolonderivater samt middel mot HIV |
JPH06199835A (ja) | 1993-01-08 | 1994-07-19 | Hokuriku Seiyaku Co Ltd | 8−ジフルオロメトキシキノリン−3−カルボン酸誘導体 |
JPH06271568A (ja) | 1993-03-22 | 1994-09-27 | Hokuriku Seiyaku Co Ltd | 7−フェニルピペラジニルキノリン−3−カルボン酸誘導体 |
JP2930539B2 (ja) | 1994-07-18 | 1999-08-03 | 三共株式会社 | トリフルオロメチルキノリンカルボン酸誘導体 |
RU2140919C1 (ru) | 1994-07-18 | 1999-11-10 | Убе Индастриз Лтд. | Производные 8-трифторметилхинолинкарбоновой кислоты, фармацевтическая композиция и способ ингибирования вируса иммунодефицита |
JPH0826772A (ja) | 1994-07-22 | 1996-01-30 | Sony Corp | 融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法 |
JP4121151B2 (ja) | 1996-04-12 | 2008-07-23 | アメリカ合衆国 | 抗新生物薬および抗レトロウイルス薬として有用なアクリドンから誘導された化合物 |
FR2761687B1 (fr) | 1997-04-08 | 2000-09-15 | Centre Nat Rech Scient | Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques |
JP3776203B2 (ja) | 1997-05-13 | 2006-05-17 | 第一製薬株式会社 | Icam−1産生阻害剤 |
GB9721964D0 (en) | 1997-10-16 | 1997-12-17 | Pfizer Ltd | Isoquinolines |
US6399629B1 (en) | 1998-06-01 | 2002-06-04 | Microcide Pharmaceuticals, Inc. | Efflux pump inhibitors |
US6248739B1 (en) | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
US6248736B1 (en) | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
PE20011349A1 (es) | 2000-06-16 | 2002-01-19 | Upjohn Co | 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales |
US6559145B2 (en) | 2000-07-12 | 2003-05-06 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
US20050010048A1 (en) | 2000-10-12 | 2005-01-13 | Linghang Zhuang | Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
EP1326610B1 (en) | 2000-10-12 | 2006-11-15 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
MXPA03007765A (es) | 2001-03-01 | 2003-12-08 | Shionogi & Co | Compuestos heteroarilo que contienen nitrogeno, que tienen actividad inhibitoria contra virus de inmunodeficiencia humana integrasa. |
JP2002293745A (ja) | 2001-03-29 | 2002-10-09 | St Marianna Univ School Of Medicine | 慢性関節リウマチ治療剤 |
US20030138483A1 (en) * | 2001-05-25 | 2003-07-24 | Sergio Petriconi | Soft elastic capsules and compositions thereof |
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
FR2827600A1 (fr) | 2001-07-20 | 2003-01-24 | Lipha | Derives acides de quinolone et leurs applications en therapeutique |
JP4035765B2 (ja) | 2002-10-31 | 2008-01-23 | 横河電機株式会社 | フーリエ変換型赤外線分光計 |
SK2662004A3 (sk) * | 2002-11-20 | 2005-06-02 | Japan Tobacco, Inc. | Zlúčenina s obsahom 4-oxochinolínu a jej použitie ako inhibítora integráz |
JP3567162B1 (ja) | 2002-11-20 | 2004-09-22 | 日本たばこ産業株式会社 | 4−オキソキノリン化合物及びそのhivインテグラーゼ阻害剤としての利用 |
MY134672A (en) * | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
US7531554B2 (en) * | 2004-05-20 | 2009-05-12 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
EP2332538A1 (en) | 2004-05-21 | 2011-06-15 | Japan Tobacco, Inc. | Combinations comprising a 4-isoquinolone derivative and anti-HIV agents |
-
2005
- 2005-05-18 MY MYPI20052258A patent/MY134672A/en unknown
- 2005-05-19 PT PT05726243T patent/PT1636190E/pt unknown
- 2005-05-19 KR KR1020087014768A patent/KR20080064909A/ko not_active Application Discontinuation
- 2005-05-19 PL PL17186674.2T patent/PL3281939T3/pl unknown
- 2005-05-19 CN CN2005800161426A patent/CN1956961B/zh active Active
- 2005-05-19 SI SI200531572T patent/SI1636190T1/sl unknown
- 2005-05-19 RS RS20120306A patent/RS52375B/en unknown
- 2005-05-19 ZA ZA200610647A patent/ZA200610647B/en unknown
- 2005-05-19 SI SI200532315T patent/SI3281939T1/sl unknown
- 2005-05-19 HR HRP20231588TT patent/HRP20231588T3/hr unknown
- 2005-05-19 EP EP23203885.1A patent/EP4299563A3/en active Pending
- 2005-05-19 MX MXPA06013405A patent/MXPA06013405A/es active IP Right Grant
- 2005-05-19 ES ES17186674T patent/ES2960824T3/es active Active
- 2005-05-19 FI FIEP17186674.2T patent/FI3281939T3/fi active
- 2005-05-19 EP EP05726243A patent/EP1636190B1/en active Active
- 2005-05-19 RU RU2006145302/04A patent/RU2330845C1/ru active
- 2005-05-19 PT PT171866742T patent/PT3281939T/pt unknown
- 2005-05-19 LT LTEP17186674.2T patent/LT3281939T/lt unknown
- 2005-05-19 PL PL05726243T patent/PL1636190T3/pl unknown
- 2005-05-19 JP JP2005147219A patent/JP3754064B2/ja active Active
- 2005-05-19 TW TW094116234A patent/TWI329015B/zh active
- 2005-05-19 EP EP17186674.2A patent/EP3281939B1/en active Active
- 2005-05-19 RS RS20231092A patent/RS64845B1/sr unknown
- 2005-05-19 DK DK17186674.2T patent/DK3281939T3/da active
- 2005-05-19 WO PCT/JP2005/009604 patent/WO2005113508A1/en active Application Filing
- 2005-05-19 AR ARP050102058A patent/AR049280A1/es not_active Application Discontinuation
- 2005-05-19 EP EP12173572A patent/EP2514746A1/en not_active Withdrawn
- 2005-05-19 NZ NZ551839A patent/NZ551839A/en unknown
- 2005-05-19 DK DK05726243.8T patent/DK1636190T3/da active
- 2005-05-19 AU AU2005245296A patent/AU2005245296B2/en active Active
- 2005-05-19 HU HUE17186674A patent/HUE064615T2/hu unknown
- 2005-05-19 BR BRPI0510114A patent/BRPI0510114B8/pt active IP Right Grant
- 2005-05-19 CA CA2566922A patent/CA2566922C/en active Active
- 2005-05-19 ES ES05726243T patent/ES2388441T3/es active Active
- 2005-05-20 US US11/133,471 patent/US7635704B2/en active Active
- 2005-05-20 PE PE2011002129A patent/PE20120361A1/es active IP Right Grant
- 2005-05-20 PE PE2005000561A patent/PE20060358A1/es active IP Right Grant
-
2006
- 2006-05-11 HK HK06105469.5A patent/HK1083341A1/xx unknown
- 2006-11-14 IL IL179250A patent/IL179250A0/en active IP Right Grant
- 2006-12-14 NO NO20065790A patent/NO339223B1/no unknown
-
2009
- 2009-08-10 US US12/538,694 patent/US8981103B2/en active Active
-
2012
- 2012-07-11 CY CY20121100621T patent/CY1113010T1/el unknown
- 2012-08-24 HR HRP20120681TT patent/HRP20120681T1/hr unknown
-
2014
- 2014-04-25 AR ARP140101722A patent/AR096100A2/es active IP Right Grant
-
2015
- 2015-01-09 US US14/593,946 patent/US20150361044A1/en not_active Abandoned
-
2016
- 2016-08-12 NO NO20161297A patent/NO20161297A1/no not_active Application Discontinuation
-
2017
- 2017-03-01 US US15/447,007 patent/US20180029989A1/en not_active Abandoned
-
2018
- 2018-07-20 US US16/041,458 patent/US20190185433A1/en not_active Abandoned
-
2019
- 2019-01-15 NO NO20190051A patent/NO20190051A1/no not_active Application Discontinuation
-
2020
- 2020-08-04 NO NO20200873A patent/NO20200873A1/no not_active Application Discontinuation
-
2021
- 2021-08-24 US US17/445,817 patent/US20220235009A1/en not_active Abandoned
-
2022
- 2022-06-17 NO NO20220690A patent/NO20220690A1/no not_active Application Discontinuation
-
2023
- 2023-08-25 NO NO20230913A patent/NO347902B1/no unknown
- 2023-11-02 FR FR23C1040C patent/FR23C1040I1/fr active Active
-
2024
- 2024-03-20 FI FIC20240008C patent/FIC20240008I1/fi unknown
- 2024-03-20 HU HUS2400006C patent/HUS2400006I1/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2400006I1 (hu) | Egy 4-oxokinolin-vegyület stabil kristályát tartalmazó kombináció | |
SI1802579T1 (sl) | Derivati 3-arilaminopiridina | |
EP1756092A4 (en) | NEW INHIBITORS OF RHO-KINASEN | |
PT1778618E (pt) | Síntese de trietilenotetraminas | |
WO2007038678A8 (en) | Analogs of ghrelin | |
EP1711484A4 (en) | SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES | |
HK1112710A1 (en) | Reducing by-catch of seabirds | |
AU157195S (en) | Watch | |
GB0410498D0 (en) | Crystal | |
IL178184A0 (en) | Synthesis of pyrrole-2-carbonitriles | |
GB0510501D0 (en) | Display of operational instructions | |
AU158223S (en) | Wristwatch | |
ZA200508325B (en) | Manufacture of kerbstones | |
SI1709057T1 (sl) | Sinteza spongozina | |
AU2004905330A0 (en) | Construction of amahs | |
PL369353A1 (pl) | Zestaw elementów budowlanych | |
GB0425577D0 (en) | Single crystal scintillators | |
GB0423342D0 (en) | Manufacture of amides | |
GB0406275D0 (en) | Modification of seed | |
GB0415064D0 (en) | Watch | |
HU2974U (en) | Fluid-displaying watch | |
PL365717A1 (en) | Forty percent solution of ammonal | |
GB0509729D0 (en) | Selection of component | |
GB0412550D0 (en) | Novel compound | |
GB0413757D0 (en) | Novel compound |